Showing 931-940 of 2876 results for "".
- Allergan Aesthetics, Girls Inc. Continue to Empower Girls Interested in STEMhttps://modernaesthetics.com/news/allergan-aesthetics-girls-inc-continue-to-empower-girls-interested-in-stem/2473126/Allergan Aesthetics is starting its third consecutive year of partnership with Girls Inc. and debuting Empowering Confidence Workshops, a nationwide mentoring initiative. Based on a 2020 Girls Inc. report, many girls have a hard time picturing themselves in science, technology, eng
- Alastin: New Study Supports Benefits of TransFORM Body Treatmenthttps://modernaesthetics.com/news/alastin-new-study-supports-benefits-of-transform-body-treatment/2473123/A clinical study and scientific article in The Aesthetic Surgery Journal (ASJ) highlights the beneficial results of daily use of TransFORM Body Treatment with TriHex Technology® (TransFORM) from Alastin Skincare. The Alastin
- Galderma Scores FDA Nod for New Cheek Fillerhttps://modernaesthetics.com/news/galderma-scores-fda-nod-for-new-cheek-filler/2473120/The U.S. Food and Drug Administration (FDA) approved Galderma’s Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21. Restylane Contour, a new hyaluronic acid (HA) dermal filler, is Galde
- Study Examines How Breast Implant Surfaces Affect Immune Responsehttps://modernaesthetics.com/news/study-examines-how-breast-implant-surfaces-affect-immune-response/2473118/Researchers are narrowing in on how breast implant surfaces may affect immune response and influence the development breast implant-associated large cell lymphoma (BIA-ALCL), and their findings may pave the way toward safer breast implants. "The surface topography of
- AACS Launches New Women in Cosmetic Surgery Sectionhttps://modernaesthetics.com/news/aacs-launches-new-women-in-cosmetic-surgery-section-new-women-in-cosmetic-surgery-section-for-members/2473117/The American Academy of Cosmetic Surgery (AACS) is launching a new forum to support the professional and personal development of female cosmetic surgeon members at all career levels. The AACS Women in Cosmetic Surgery Se
- Toxic Chemicals Found in More than Half of US Make-Up Productshttps://modernaesthetics.com/news/toxic-chemicals-found-in-more-than-half-of-us-make-up-products/2473116/More than half of the make-up products sold in the United States and Canada may contain toxic chemicals, a new study suggests. When researchers out of the University of Notre Dame tested 231 com
- New from Nutrafol: Postpartum Formulahttps://modernaesthetics.com/news/new-from-nutrafol-postpartum-formula/2473115/The first-of-its-kind postpartum hair nutraceutical is now available from Nutrafol. Nutrafol Postpartum was developed with an OB/GYN to target the root causes of excess hair shedding and thinning post-pregnancy. It is intended to help the body recover from the physical stress of childbirth,
- Merz Aesthetics Rolls Out New Online Medical Education Forumhttps://modernaesthetics.com/news/merz-aesthetics-rolls-out-new-medical-education-forum/2473114/Merz Aesthetics is launching Merz Aesthetics Medical Forum, an online medical aesthetics education platform for health care professionals around the world. Established by Merz Aesthetics Global Medical Affairs, the Medical Forum provides on-demand content focused on medical aesthe
- Allergan Aesthetics and Botox Cosmetic Release "See Yourself" Campaign Featuring Real Stories from Real Patientshttps://modernaesthetics.com/news/allergan-aesthetics-and-botox-cosmetic-release-see-yourself-campaign-featuring-real-stories-from-real-patients/2473110/Allergan Aesthetics is launching "See Yourself," a new campaign featuring documentary-style shorts that tell the stories of real Botox Cosmetic patients. "This campaign is just the beginning, our goal is that through authentic storytelling, people will connect with t
- Sofwave Medical Goes Public on the Tel Aviv Stock Exchange, Raises $50Mhttps://modernaesthetics.com/news/sofwave-medical-goes-public-on-the-tel-aviv-stock-exchange-raises-50m/2473109/Sofwave Medical made its initial public offering (IPO) on the Tel Aviv Stock Exchange (TASE) and raised $50 million at a pre-money valuation of ~$200 million. The IPO was led by Barak Capital Underwriters. The company has developed Synchronous Ul